283 related articles for article (PubMed ID: 14968297)
21. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
22. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
23. Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line).
Solé M; Hernandez M; Boada M; Unzeta M
J Neural Transm (Vienna); 2007; 114(6):763-7. PubMed ID: 17393062
[TBL] [Abstract][Full Text] [Related]
24. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
[TBL] [Abstract][Full Text] [Related]
25. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes.
Morin N; Lizcano JM; Fontana E; Marti L; Smih F; Rouet P; Prévot D; Zorzano A; Unzeta M; Carpéné C
J Pharmacol Exp Ther; 2001 May; 297(2):563-72. PubMed ID: 11303044
[TBL] [Abstract][Full Text] [Related]
26. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
27. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
Yraola F; García-Vicente S; Fernandez-Recio J; Albericio F; Zorzano A; Marti L; Royo M
J Med Chem; 2006 Oct; 49(21):6197-208. PubMed ID: 17034126
[TBL] [Abstract][Full Text] [Related]
28. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme.
Bonaiuto E; Lunelli M; Scarpa M; Vettor R; Milan G; Di Paolo ML
Biochimie; 2010 Jul; 92(7):858-68. PubMed ID: 20298739
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
30. [Determination of the activity of semicarbazide-sensitive amine oxidase in the differentiated 3T3-F442A cells by enzyme-linked spectrophotometric assay].
Zhu S; Wang Y; Du Y; Li S; Xuan X; Tang Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Oct; 25(5):1161-5. PubMed ID: 19024467
[TBL] [Abstract][Full Text] [Related]
31. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
Hernandez-Guillamon M; Solé M; Delgado P; García-Bonilla L; Giralt D; Boada C; Penalba A; García S; Flores A; Ribó M; Alvarez-Sabin J; Ortega-Aznar A; Unzeta M; Montaner J
Cerebrovasc Dis; 2012; 33(1):55-63. PubMed ID: 22133888
[TBL] [Abstract][Full Text] [Related]
32. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats.
Somfai GM; Knippel B; Ruzicska E; Stadler K; Tóth M; Salacz G; Magyar K; Somogyi A
Neurochem Int; 2006 Jun; 48(8):746-52. PubMed ID: 16524643
[TBL] [Abstract][Full Text] [Related]
33. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition.
Bour S; Caspar-Bauguil S; Iffiú-Soltész Z; Nibbelink M; Cousin B; Miiluniemi M; Salmi M; Stolen C; Jalkanen S; Casteilla L; Pénicaud L; Valet P; Carpéné C
Am J Pathol; 2009 Mar; 174(3):1075-83. PubMed ID: 19218346
[TBL] [Abstract][Full Text] [Related]
34. Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
Hernandez-Guillamon M; Garcia-Bonilla L; Solé M; Sosti V; Parés M; Campos M; Ortega-Aznar A; Domínguez C; Rubiera M; Ribó M; Quintana M; Molina CA; Alvarez-Sabín J; Rosell A; Unzeta M; Montaner J
Stroke; 2010 Jul; 41(7):1528-35. PubMed ID: 20538694
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of glucose transport by semicarbazide-sensitive amine oxidase activity in adipocytes from diabetic rats.
Abella A; Marti L; Carpéné C; Palacín M; Testar X; Zorzano A
J Physiol Biochem; 2003 Sep; 59(3):153-60. PubMed ID: 15000445
[TBL] [Abstract][Full Text] [Related]
37. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation.
Boomsma F; Hut H; Bagghoe U; van der Houwen A; van den Meiracker A
Med Sci Monit; 2005 Apr; 11(4):RA122-6. PubMed ID: 15795708
[TBL] [Abstract][Full Text] [Related]
38. Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity.
Marti L; Abella A; De La Cruz X; García-Vicente S; Unzeta M; Carpéné C; Palacín M; Testar X; Orozco M; Zorzano A
J Med Chem; 2004 Sep; 47(20):4865-74. PubMed ID: 15369390
[TBL] [Abstract][Full Text] [Related]
39. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
40. Semicarbazide-sensitive amine oxidase in transgenic mice with diabetes.
Gokturk C; Nordquist J; Sugimoto H; Forsberg-Nilsson K; Nilsson J; Oreland L
Biochem Biophys Res Commun; 2004 Dec; 325(3):1013-20. PubMed ID: 15541390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]